Подписаться
Sergey Kulemzin
Sergey Kulemzin
Researcher, Institute of Molecular and Cellular Biology SB RAS
Подтвержден адрес электронной почты в домене mcb.nsc.ru
Название
Процитировано
Процитировано
Год
Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II
I Akhrymuk, SV Kulemzin, EI Frolova
Journal of virology 86 (13), 7180-7191, 2012
2472012
COVID-19. Aetiology, pathogenesis, diagnosis and treatment
VP Baklaushev, SV Kulemzin, АА Gorchakov, VN Lesnyak, ...
Journal of Clinical Practice 11 (1), 7-20, 2020
772020
Challenges and prospects of chimeric antigen receptor T-cell therapy for metastatic prostate cancer
AA Gorchakov, SV Kulemzin, GV Kochneva, AV Taranin
European urology 77 (3), 299-308, 2020
472020
FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA
T Santiago, SV Kulemzin, ES Reshetnikova, NA Chikaev, OY Volkova, ...
International immunology 23 (1), 43-53, 2011
422011
Engineering chimeric antigen receptors
SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin
Acta Naturae (англоязычная версия) 9 (1 (32)), 6-14, 2017
302017
Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern
AA Gorchakov, SV Kulemzin, SV Guselnikov, KO Baranov, ...
Cell Discovery 7 (1), 96, 2021
292021
VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells
SV Kulemzin, AA Gorchakov, AN Chikaev, VV Kuznetsova, OY Volkova, ...
Oncotarget 9 (10), 9021, 2018
252018
FCRL6 receptor: Expression and associated proteins
SV Kulemzin, AY Zamoshnikova, MY Yurchenko, NY Vitak, AM Najakshin, ...
Immunology letters 134 (2), 174-182, 2011
252011
Memory B cells induced by Sputnik V vaccination produce SARS-CoV-2 neutralizing antibodies upon ex vivo restimulation
MG Byazrova, SV Kulemzin, EA Astakhova, TN Belovezhets, GA Efimov, ...
Frontiers in Immunology 13, 840707, 2022
222022
Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines
SV Kulemzin, DA Matvienko, AH Sabirov, AM Sokratyan, DS Chernikova, ...
BMC medical genomics 12, 87-95, 2019
222019
Strategies to circumvent the side-effects of immunotherapy using allogeneic CAR-T cells and boost its efficacy: Results of recent clinical trials
S Smirnov, A Petukhov, K Levchuk, S Kulemzin, A Staliarova, K Lepik, ...
Frontiers in Immunology 12, 780145, 2021
192021
shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
VG Subrakova, SV Kulemzin, TN Belovezhets, AN Chikaev, NA Chikaev, ...
Vavilov Journal of Genetics and Breeding 24 (1), 80, 2020
142020
Combination of oncolytic virotherapy and car t/nk cell therapy for the treatment of cancer
GV Kochneva, GF Sivolobova, AV Tkacheva, AA Gorchakov, SV Kulemzin
Molecular Biology 54, 1-12, 2020
132020
CAR T-cell therapy: Balance of efficacy and safety
SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin, AA Gorchakov
Molecular Biology 51, 237-250, 2017
102017
Diversity of immunoglobulin light chain genes in non-teleost ray-finned fish uncovers IgL subdivision into five ancient isotypes
SV Guselnikov, KO Baranov, AM Najakshin, LV Mechetina, NA Chikaev, ...
Frontiers in Immunology 9, 2018
92018
Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination
EA Astakhova, MG Byazrova, GM Yusubalieva, SV Kulemzin, ...
Cells 11 (13), 1991, 2022
82022
Characterization of human FCRLA isoforms
S Kulemzin, N Chikaev, O Volkova, E Reshetnikova, A Taranin, ...
Immunology letters 152 (2), 153-158, 2013
82013
Modular lentiviral vector system for chimeric antigen receptor design optimization
SV Kulemzin, NA Chikaev, OY Volkova, VV Kuznetsova, AV Taranin, ...
Russian Journal of Bioorganic Chemistry 43, 107-114, 2017
72017
Development and Characterization of Domain-Specific Monoclonal Antibodies Produced Against Human SLAMF9
O Volkova, S Guselnikov, L Mechetina, N Chikaev, K Baranov, ...
Monoclonal antibodies in immunodiagnosis and immunotherapy 33 (4), 209-214, 2014
72014
Analysis of in vitro activity of PSCA-specific CARs in the context of human NK cell line YT
DA Matvienko, SV Kulemzin, AS Smagina, TN Belovezhets, AN Chikaev, ...
Cell Ther. Transplant. 7, 70-76, 2018
52018
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20